Diane M Harper

Post Hoc Analysis of the PATRICIA Randomized Trial of the Efficacy of Human Papillomavirus Type 16 (HPV-16)/HPV-18 AS04-Adjuvanted Vaccine against Incident and Persistent Infection with Nonvaccine Oncogenic HPV Types Using an Alternative Multiplex Type-Specific PCR Assay for HPV DNA

Frank Struyf, Brigitte Colau, Cosette M Wheeler, 2014, Clinical and Vaccine Immunology.

Efficacy of a bivalent L 1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial

Daron G Ferris, Wim Quint, Diane M Harper, 2005 .

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Daron G Ferris, Cosette M Wheeler, Diane M Harper, 2007, The New England journal of medicine.

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

Daron G Ferris, Diane M Harper, Gary Dubin, 2004, The Lancet.

Optical detection of high-grade cervical intraepithelial neoplasia in vivo: results of a 604-patient study.

Diane M Harper, D. Harper, Francisco A. R. Garcia, 2004, American journal of obstetrics and gynecology.

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Cosette M Wheeler, Diane M Harper, Mark H Stoler, 2005, The Lancet. Oncology.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Henry C Kitchener, Bart Spiessens, Frank Struyf, 2007, The Lancet.